Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol.

MLA

Bramer, S. L., and W. P. Forbes. “Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cilostazol.” Clinical Pharmacokinetics, vol. 37 Suppl 2, 1999, pp. 25–32. EBSCOhost, https://doi.org/10.2165/00003088-199937002-00003.

APA

Bramer, S. L., & Forbes, W. P. (1999). Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol. Clinical Pharmacokinetics, 37 Suppl 2, 25–32. https://doi.org/10.2165/00003088-199937002-00003

Chicago

Bramer, S L, and W P Forbes. 1999. “Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cilostazol.” Clinical Pharmacokinetics 37 Suppl 2: 25–32. doi:10.2165/00003088-199937002-00003.